Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure - Trial NCT06400927
Access comprehensive clinical trial information for NCT06400927 through Pure Global AI's free database. This phase not specified trial is sponsored by East and North Hertfordshire NHS Trust and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
East and North Hertfordshire NHS Trust
Timeline & Enrollment
N/A
Jun 13, 2024
Sep 13, 2027
Primary Outcome
Acceptability of the intervention to users (participants)
Summary
The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual
 assistant (VA) into the outpatient management of participants recently discharged from
 hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical
 assessment and the healthcare burden, reduce variability in healthcare, and meet with
 participant satisfaction, without compromising participant safety and overall care quality.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06400927
Non-Device Trial